Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation

American Journal of Transplantation

Volumn 5, Issue 2, 2005, Pages 330-340

  Brouard, Sophie ^a   Dupont, Alexandre ^a   Giral, Magali ^a   Louis, Stéphanie ^a   Lair, David ^a   Braudeau, Cécile ^a   Degauque, Nicolas ^a   Moizant, Frédérique ^a   Pallier, Annaick ^a   Ruiz, Catherine ^a   Guillet, Marina ^a   Laplaud, David ^a   Soulillou, Jean Paul ^a  

^a HÔTEL DIEU   (France)

Author keywords

Kidney transplantation; T cells; T cell receptor; Tolerance

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TIME FACTORS;

EID: 19944432468     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00700.x     Document Type: Article

References (37)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612.
2. Opelz G. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study. Kidney Int Suppl 1995; 52: S89-S92.
3. Soulillou JP, Giral M. Controlling the incidence of infection and malignancy by modifying immunosuppression. Transplantation 2001; 72(12 Suppl.): S89-S93.
4. Giral M, Pascuariello G, Karam G et al. Acute graft pyelonephritis and long-term kidney allograft outcome. Kidney Int 2002; 61: 1880-1886.
5. Dantal J, Hourmant M, Cantarovich D et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351: 623-628.
6. Strober S, Benike C, Krishnaswamy S, Engleman EG, Grumet FC. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Transplantation 2000; 69: 1549-1554.
7. Jacobsen N, Taaning E, Ladefoged J, Kristensen JK, Pedersen FK. Tolerance to an HLA-B, DR disparate kidney allograft after bone-marrow transplantation from same donor. Lancet 1994; 343: 800.
8. Burlingham WJ, Grailer AP, Fechner JH, Jr. et al. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 1995; 59: 1147-1155.
9. Zoller KM, Cho SI, Cohen JJ, Harrington JT. Cessation of immunosuppressive therapy after successful transplantation: a national survey. Kidney Int 1980; 18: 110-114.
10. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000; 106: 145-155.
11. Ciubotariu R, Liu Z, Colovai AI et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998; 101: 398-405.
12. Douillard P, Pannetier C, Josien R et al. Donor-specific blood transfusion-induced tolerance in adult rats with a dominant TCR-Vbeta rearrangement in heart allografts. J Immunol 1996; 157: 1250-1260.
13. Brouard S, Vanhove B, Gagne K et al. T cell repertoire alterations of vascularized xenografts. J Immunol 1999; 162: 3367-3377.
14. Pannetier C, Even J, Kourilsky P. T cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995; 16: 176-181.
15. Gorochov G, Neumann AU, Kereveur A et al. Perturbation of CD4+ and CD8+ T cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med 1998; 4: 215-221.
16. Sebille F, Gagne K, Guillet M et al. Direct recognition of foreign MHC determinants by naive T cells mobilizes specific Vbeta families without skewing of the complementarity-determining region 3 length distribution. J Immunol 2001; 167: 3082-3088.
17. Guillet M, Sebille F, Soulillou J. TCR usage in naive and committed alloreactive cells: implications for the understanding of TCR biases in transplantation. Curr Opin Immunol 2001; 13: 566-571.
18. Josien R, Heslan M, Brouard S, Soulillou JP, Cuturi MC. Critical requirement for graft passenger leukocytes in allograft tolerance induced by donor blood transfusion. Blood 1998; 92: 4539-4544.
19. Waldmann H, Cobbold S. Regulating the immune response to transplants, a role for CD4+ regulatory cells? Immunity 2001; 14: 399-406.
20. Zhai Y, Li J, Hammer M, Busuttil RW, Volk HD, Kupiec-Weglinski JW. Evidence of T cell clonality in the infectious tolerance pathway: implications toward identification of regulatory T cells. Transplantation 2001; 71: 1701-1708.
21. Baron C, McMorrow I, Sachs DH, LeGuern C. Persistence of dominant T cell clones in accepted solid organ transplants. J Immunol 2001; 167: 4154-4160.
22. Baron C, Sachs DH, LeGuern C. A particular TCR beta variable region used by T cells infiltrating kidney transplants. J Immunol 2001; 166: 2589-2596.
23. Guillet M, Brouard S, Gagne K et al. Different qualitative and quantitative regulation of Vbeta TCR transcripts during early acute allograft rejection and tolerance induction. J Immunol 2002; 168: 5088-5095.
24. Schwartz RH. Models of T cell anergy: is there a common molecular mechanism? J Exp Med 1996; 184: 1-8.
25. Douillard P, Vignes C, Josien R et al. Reassessment of the role of CDS+ T cells in the induction of allograft tolerance by donor-specific blood transfusion. Eur J Immunol 1999; 29: 1919-1924.
26. Ciubotariu R, Vasilescu R, Ho E et al. Detection of T suppressor cells in patients with organ allografts. Hum Immunol 2001; 62: 15-20.
27. Vella JP, Spadafora-Ferreira M, Murphy B et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997; 64: 795-800.
28. Schwab R, Szabo P, Manavalan JS et al. Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol 1997; 158: 4493-4499.
29. Ku CC, Kappler J, Marrack P. Characteristics and maintenance of CD8+ T cell clones found in old mice. Mech Ageing Dev 1997; 94: 41-53.
30. Ku CC, Kappler J, Marrack P. The growth of the very large CD8+ T cell clones in older mice is controlled by cytokines. J Immunol 2001; 166: 2186-2193.
31. Colombatti A, Doliana R, Schiappacassi M, et al. Age-related persistent clonal expansions of CD28- cells: phenotypic and molecular TCR analysis reveals both CD4+ and CD4+CD8+ cells with identical CDR3 sequences. Clin Immunol Immunopathol 1998; 89: 61-70.
32. Ricalton NS, Roberton C, Norris JM, Rewers M, Hamman RF, Kotzin BL. Prevalence of CD8+ T cell expansions in relation to age in healthy individuals. J Gerontol A Biol Sci Med Sci 1998; 53: B196-B203.
33. Halapi E, Jeddi-Tehrani M, Blucher A et al. Diverse T-cell receptor CDR3 length patterns in human CD4+ and CD8+ T lymphocytes from newborns and adults. Scand J Immunol 1999; 49: 149-154.
34. Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto MF, Quaglino D. Immunological changes in the elderly. Aging (Milano) 1999; 11: 281-286.
35. Marrack P, Lo D, Brinster R et al. The effect of thymus environment on T cell development and tolerance. Cell 1988; 53: 627-634.
36. Strom TB, Tilney NL, Carpenter CB, Busch GJ. Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med 1975; 292: 1257-1263.
37. Thomson AW, Mazariegos GV, Reyes J et al. Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation 2001; 72(8 Suppl.): S13-S22.